KAIST 생명과학과동창회
  • News & Events
  • News

News

Growing up curious in the countryside leads to tools for manipulating endogenous proteins.

 

 

허원도 교수님 사진.jpg



Won Do Heo

“Good ideas come to me when I am very comfortable, when I am very happy,” says Won Do Heo, who is on the biology faculty at Korea Advanced Institute of Science and Technology (KAIST), and is a neuroscience fellow at the Institute for Basic Science, both in Daejon, Republic of Korea. An idea might come to him in a lab conversation, at a seminar or conference, when he is jogging, on one of his daily walks on a hill, or in the sauna at home.

 

It was a Korean national holiday and Heo was alone in the lab, thinking. He had spent a decade developing and using optogenetic tools. Suddenly, he realized how he might finally turn intrabodies, which are antibodies used to study intracellular proteins, into inducible tools.

 

Heo and his lab converted the idea into two classes of tools to target and manipulate proteins inside cells: optobodies, which can be activated by light; and chemobodies, which can be activated by small molecules. These tools leverage nanobodies, based on camelid antibodies, that are prized in cell biology for being soluble and small they’re around half the size of a green fluorescent protein molecule.

 

During that holiday musing, Heo had figured out at which cysteine residues he could split the nanobody to generate two inactive parts that do not bind a targeted protein. He checked the nanobody structure, and experiments got underway. The split structure lets an experimenter use light to, for example, activate or inhibit a protein at the cell membrane, at an organelle or in the cell nucleus. When the nanobody halves are separate, it’s like having only one chopstick for a meal, he says. Work only gets done when the other half enters the scene.

 

The tools offer high-resolution temporal and spatial information about endogenous proteins, says Heo. With optobodies, light can help with manipulating a targeted protein and thus shape cell function. The team’s chemobody would be good for an in vivo experiment, he says. Such studies, for example in neurobiology, are on his to-do list.

 

The lab used blue light to activate the optobody, but Heo believes he can get the tools to work with infrared light, too. Although there are many types of nanobodies, he believes the tools will work across this antibody class and for many types of questions. The chosen split site is in the antibody’s highly conserved domain.

 

In his lab, says Heo, tool development involves intense testing, which takes a collaborative lab culture. Lab members not involved in a project are a tool’s first users. This arrangement is not easy given his students’ eagerness to publish quickly. But Heo seeks generalizable, broadly applicable tools. “I don’t make very special, very tricky things,” he says, which might only work in a few labs.

 

In his lab, Heo encourages his students to explore projects that intrigue them and that will make them happy during their years in his lab. “If they are not happy with something, I won’t be happy, too.”

 

Heo grew up on a farm in the country. “I didn’t really have the plan to be a professorresearcher at the time,” he says. He played with his dog, rabbit and cows, and was curious about how they interacted and cared for their young. He learned about rice and barley farming. “It’s not textbook, it’s just nature,” he says. In high school, he began breeding birds: peacocks, turkeys, pheasants, parrots and canaries.

 

Even college was not in his plans, but curiosity led him to Gyeongsang National University. “I realized that I had to step up to another level,” he says. Heo studied plant biology and switched to biochemistry in graduate school.

 

For his postdoctoral fellowship, curiosity was again a driver. He wanted to work in mammalian systems, and joined the Duke University lab of Tobias Meyer. Heo followed Meyer to Stanford University where, after a few years, he was promoted to staff researcher. After nine years in California, Heo joined KAIST and chose to focus on optogenetics.

 

Heo feels he can now combine his experience across fields: plant biology, cell biology, cell signaling and neurobiology. As Heo completed his PhD, he remembers realizing that many plant proteins are not present in mammals, which might make them useful tools, he says. This idea has emerged as a cornerstone of optogenetics.

 

Optogenetics has taken cell biology labs beyond observation, which might miss half of the actual cellular events. Cells “are talking to each other, communicating to each other,” he says. The ability to activate or deactivate proteins with light gives labs a way to explore cell biology more deeply and can help them, for example, determine proteins crucial to the cell cycle.

 

“If they are not happy with something, I won’t be happy.”

 

“I admire Won Do’s work for its creativity; he has applied optical control by the cryptochromeCIB1 interaction in very imaginative ways,” says Heo’s friend and colleague, Stanford University researcher Michael Lin. Heo and his students don’t shy away from the hard work necessary to realize their ideas, says Lin. “Developing truly new methods is high-risk and time-consuming, but Won Do has shown that the high rewards make it worth it.”



출처: Nature Methods > This month >

       https://www.nature.com/articles/s41592-019-0626-1


List of Articles
번호 제목 글쓴이 날짜 조회 수
412 [강석조 교수님] 이행 호염구, 알레르기 매개 세포에 대한 새로운 이해 생명과학과 2023.11.08 307
411 [정인경 교수님] 기저 질환이 없는 코로나19 환자의 중증 신규 유전적 위험 인자 규명 생명과학과 2022.09.29 336
410 [강창원, 서연수 교수님, 팔린다 박사님] 논문 Nucleic Acids Research 게재 생명과학과 2023.02.17 345
409 [정인경 교수님] 암, 노화 등에 미치는 게놈 3차 구조의 신규 원리 발견​ 생명과학과 2023.04.10 348
408 [메디포럼 정재언 대표] 메디포럼, 정재언 연구소장 신임 대표이사 선임…“임상 R&D 중심 경영 집중” 생명과학과 2022.03.14 371
407 [김학성 교수님, 김홍식 박사님] 암세포에만 약물 전달 가능한 클라트린 조립체 개발​ 생명과학과 2023.03.15 382
406 [김진우 교수님] 새로운 세포핵 단백질의 이동 루트 발견​ 생명과학과 2023.02.28 382
405 [김은준 교수님] 자폐 진단․ 치료 골든타임, 동물실험으로 확인 생명과학과 2022.09.27 389
404 [김찬혁 교수님] 말기 고형암 표적 2세대 면역치료제 개발​ 생명과학과 2023.04.20 399
403 [이승희 교수님] 신경전달물질 소마토스타틴의 알츠하이머 독성 개선효과 발견​ 생명과학과 2022.07.25 405
402 [김은준 교수님] 대규모 한국인 자폐증 가족 유전체 연구를 통한 새로운 자폐 유전변이 최초 발견​ 생명과학과 2022.07.19 410
401 [김보람 박사님(서성배 교수님 연구실)] 한국뇌연구원 제2회 다한우수논문상 선정 생명과학과 2022.12.07 413
400 [전상용, 조병관 교수님] 나노입자로 염증부터 면역치료까지 가능 생명과학과 2023.06.21 417
399 [송지준 교수님] 헌팅턴병 발병원인 제거를 위한 치료제 개발 방법 제시​ 생명과학과 2022.09.02 423
398 [루닛 서범석 대표] 바이오업계 유니콘 기대 루닛, 서범석 '치료 예측 AI' 고도화 박차 생명과학과 2022.04.27 424
397 충북도, 글로벌 바이오 캠퍼스 유치에 KAIST와 '맞손' 생명과학과 2022.03.15 434
396 [정인경 교수님] 파킨슨병 발병 3차원 게놈 지도 최초 제시​ 생명과학과 2023.05.08 439
395 [오병하 교수님] 오미크론에도 듣는 범용 항체, 국내에서 개발 생명과학과 2022.02.04 442
394 [이승재 교수님] 건강한 장수를 유도하는 돌연변이 유전자 발굴 생명과학과 2021.11.24 446
393 [김대수 교수님] 네이버 열린연단 '자유와 이성' 주제로 시즌9 강연 시작 생명과학과 2022.04.22 446
Board Pagination Prev 1 2 3 4 5 6 7 8 9 10 ... 22 Next
/ 22